1.. Introduction
================

It has been well confirmed of key roles of oxidized low-density lipoprotein (ox-LDL) in the development of atherosclerosis \[[@b1-ijms-14-22708]\] Endothelial cells, macrophages, and smooth muscle cells, which are involved in atherosclerosis, exhibit atherosclerotic alterations, post exposing to ox-LDL *in vitro* \[[@b2-ijms-14-22708]\]. Ox-LDL is known to induce apoptosis, monocyte adhesion, and reactive oxygen species generation \[[@b3-ijms-14-22708]--[@b5-ijms-14-22708]\] via binding to the lectin-like endothelial ox-LDL receptor (LOX-1) \[[@b4-ijms-14-22708]\] on the vascular endothelial cells. The ox-LDL can also upregulate in endothelial cells, the LOX-1 expression, which can also be induced by cytokine tumor necrosis factor-α (TNF-α) \[[@b6-ijms-14-22708]\], and angiotensin II \[[@b7-ijms-14-22708]\] as well.

The ox-LDL-induced apoptosis via binding to LOX-1 in vascular endothelial cells \[[@b4-ijms-14-22708],[@b8-ijms-14-22708]\], or in vascular smooth muscle cells \[[@b9-ijms-14-22708]\], has been well determined. And it has shown that caspases, *i.e.*, caspase-9 and caspase-3, but not caspase-8, play roles in the ox-LDL-induced apoptotic signaling pathway \[[@b8-ijms-14-22708]\] in human coronary artery endothelial cells (HCAECs). In addition, ox-LDL also induces apoptosis via inhibiting of NF-κB \[[@b10-ijms-14-22708]\], or via modulating Bax/Bcl-2 in VSMCs. These findings provide new insights into the role of LOX-1 in ox-LDL-mediated endothelial injury.

MicroRNAs (miRNAs) are a novel class of endogenous, noncoding RNAs molecules (about 22 nucleotides long) that can bind the 3′-untranslated region of target messenger RNA (mRNA) and regulate gene expression \[[@b11-ijms-14-22708]\]. The role of miRNAs in the cardiovascular system has just been revealed \[[@b12-ijms-14-22708]\]. MiR-21 poses a proproliferative and anti-apoptotic effect on vascular smooth muscle cells (VSMCs) \[[@b13-ijms-14-22708]\]. More effort needs to be made on this issue. More recently, a negative feedback regulation has been identified between microRNA let-7g and the ox-LDL receptor LOX-1: ox-LDL can reduce let-7g expression, while the let-7g can down-regulate the LOX-1 expression \[[@b14-ijms-14-22708]\]. Furthermore, the down-regulation of the hsa-let-7g on LOX-1 expression has also been identified in human smooth muscle cells, in which, apoptosis is induced by the down-regulation \[[@b15-ijms-14-22708]\].

Caspase-3 (CASP3) is a member of the cysteine-aspartic acid protease (caspase) family \[[@b16-ijms-14-22708]\], which are sequentially activated and play a central role in the execution-phase of cell apoptosis. The CASP3 plays key role in apoptosis execution, post being activated from proCASP3, mainly by CASP3 itself, caspase-8, caspase-9, caspase-10, the CASP3, along with caspase-6, caspase-7, which are activated by it, executes the apoptotic cell death \[[@b17-ijms-14-22708]\]. Sporadic reports show that microRNA let-7, *i.e.*, let-7a and let-7e, regulate the expression of CASP3 during apoptosis \[[@b18-ijms-14-22708],[@b19-ijms-14-22708]\]. It's interesting to explore whether there are other microRNAs involved in the regulation of apoptosis induced by ox-LDL.

To further determine the anti-atherosclerosis effect of microRNA has-let-7g, and to evaluate the possibility of CASP3 as an anti-atherosclerotic drug target by has-let-7g, the present study determined the role of hsa-let-7g miRNA in ox-LDL induced apoptosis in the vascular endothelial cells.

2.. Results
===========

2.1.. Ox-LDL Reduces EAhy926 Vascular Endothelial Cells Viability via Inducing the Cell Apoptosis
-------------------------------------------------------------------------------------------------

To observe the influence of ox-LDL on the EAhy926 cells viability, the MTT assay was conducted, it was shown in [Figure 1a](#f1-ijms-14-22708){ref-type="fig"} that the treatment with ox-LDL could reduce the cell viability with a dose of 30 μg/mL, post 12 or 24 h treatment (82.97% ± 5.60% for 10 μg/mL ox-LDL, or 72.00% ± 2.85% for 30 μg/mL ox-LDL *vs.* 90.07% ± 3.37% for control, *p* = 0.29 and *p* = 0.021 respectively; 72.3% ± 5.91% for 10 μg/mL ox-LDL, or 59.63% ± 4.89% for 30 μg/mL ox-LDL *vs.* 84.6% ± 5.38% for control, *p* = 0.20 and *p* = 0.023 respectively). Ox-LDL-induced apoptosis has been reported in various cell models, *i.e.*, vascular endothelial cells \[[@b4-ijms-14-22708],[@b8-ijms-14-22708]\] and vascular smooth muscle cells \[[@b9-ijms-14-22708]\], and it was further determined whether the decreased EAhy926 cell viability was caused by apoptosis. [Figure 1b--d](#f1-ijms-14-22708){ref-type="fig"} demonstrated significantly increased apoptosis after treatment with ox-LDL (30 μg/mL) for 24 or 48 h (*p* \< 0.01 respectively). To further confirm the apoptosis is induced by ox-LDL, the expression of ox-LDL receptor, LOX-1, was measured in mRNA level and protein level. It showed that the ox-LDL induced significant high level of LOX-1 mRNA expression ([Figure 2a,b](#f2-ijms-14-22708){ref-type="fig"}) and significant high expression of LOX-1 in protein level ([Figure 2c,d](#f2-ijms-14-22708){ref-type="fig"}).

To further evaluate the ox-LDL-induced apoptosis in EAhy926 cells, the expression in mRNA and protein levels of proapoptotic protein Bax, apoptosis executioner CASP3 were also assayed by quantitative RT-PCR and western blotting assay; it was shown that both Bax and CASP3 were expressed significantly high in both mRNA ([Figure 2a,b](#f2-ijms-14-22708){ref-type="fig"}) and protein level ([Figure 2c,d](#f2-ijms-14-22708){ref-type="fig"}) in the EAhy926 cells post ox-LDL treatment.

2.2.. Hsa-Let-7g miRNA Is Downregulated during the Ox-LDL-Induced EAhy926 Cell Apoptosis
----------------------------------------------------------------------------------------

It has been demonstrated that ox-LDL decreases let-7g promoter activity and downregulates the expression of the microRNA in the primary human aortic smooth muscle cells, and there is a negative feedback regulation between microRNA let-7g and the ox-LDL receptor LOX-1 \[[@b14-ijms-14-22708]\]. To test the hypothesis that ox-LDL inhibited the let-7g gene expression during the ox-LDL-induced apoptosis in EAhy926 cells, we compared the Hsa-let-7g miRNA expression between the ox-LDL-treated and non-treated EAhy926 cells. As showed in [Figure 3a](#f3-ijms-14-22708){ref-type="fig"}, the hsa-let-7g expression in EAhy926 cells post ox-LDL treatment was significantly lower than in the non-treated cells (*p* \< 0.05). To further evaluate the downregulation of let-7g by ox-LDL, the mRNA expression of miRNA processing enzymes, Drosha and Dicer, was tested by the RT-qPCR, but surprisingly, the microRNA processing enzymes Drosha and Dicer were upregulated post the ox-LDL treated, in mRNA level ([Figure 3b,c](#f3-ijms-14-22708){ref-type="fig"}) and protein level ([Figure 3d,e](#f3-ijms-14-22708){ref-type="fig"}). It seems that more microRNAs being involved post ox-LDL treatment.

2.3.. Hsa-Let-7g miRNA Inhibits the Apoptosis Induced by ox-LDL
---------------------------------------------------------------

An ox-LDL-induced apoptosis and has-let-7g downregulation were confirmed in EAhy926 endothelial cells. In addition, to investigate the association of has-let-7g downregulation with the apoptosis in the cells, we manipulated let-7g level in EAhy926 cells by transfecting with has-let-7g mimics. When 50 nM has-let-7g mimics was transfected into EAhy926 cells, the level of let-7g increased up to 850-fold 24 h post transfection or 615-fold 48 h post transfection ([Figure 4a](#f4-ijms-14-22708){ref-type="fig"}). It showed that let-7g miRNA mimics in the EAhy926 cells significantly diminished the ability of ox-LDL to induce apoptosis ([Figure 4b](#f4-ijms-14-22708){ref-type="fig"}). The regulation of let-7g on Bax and CASP3 were also assayed by quantitative RT-PCR and western blotting assay; it was shown that the ox-LDL induced Bax induction was suppressed in mRNA level by the has-let-7g mimics ([Figure 4c](#f4-ijms-14-22708){ref-type="fig"}); and the upregulation of CASP3 by ox-LDL was significantly suppressed by has-let-7g mimics in both mRNA level ([Figure 4d](#f4-ijms-14-22708){ref-type="fig"}) and in protein level ([Figure 4e,f](#f4-ijms-14-22708){ref-type="fig"}). These data suggest that the specific repression of has-let-7g contributes to ox-LDL-induced apoptosis of EAhy926 cells *in vitro*.

2.4.. Hsa-Let-7g Targets 3′ UTR of CASP3 and Inhibits CASP3 Expression
----------------------------------------------------------------------

It was shown that during the apoptosis blocking by has-let-7g mimics in EAhy926 cells, CASP3 was more significantly inhibited than Bax (*p* \< 0.01 *vs. p* \< 0.05, [Figure 4e,f](#f4-ijms-14-22708){ref-type="fig"}). Analysis with software TargetScan demonstrated that the first eight nucleotides (seed sequence) from the 5′ end of let-7g miRNA were complementary to the 153-159 nucleotides of the CASP3 3′ UTR ([Figure 5a](#f5-ijms-14-22708){ref-type="fig"}). The CASP3 3′ UTR mRNA has a perfect match with the seed sequence of has-let-7g. In order to evaluate the possible targeting of CASP3 by let-7g in EAhy926 cells, the CASP3 expression in mRNA and protein levels was determined post the has-let-7g mimics or miRNA control transfection into the endothelial cells. It was shown that the pro-CASP3 protein was down-regulated after transfection with has-let-7g mimics while there was no effect for the control transfection ([Figure 5b,e,f](#f5-ijms-14-22708){ref-type="fig"}).

To further elucidate the hypothesis, the luciferase reporter constructs containing the let-7g recognition sequence of CASP3 mRNA immediately downstream of luciferase gene were utilized ([Figure 5c](#f5-ijms-14-22708){ref-type="fig"}). As shown in [Figure 5d](#f5-ijms-14-22708){ref-type="fig"}, transfection with the has-let-7g mimics suppressed while the miRNA control didn't regulate the activity of pGL-CASP3 reporter in EAhy926 cells. These results therefore agree with the fact that let-7g regulates CASP3 by targeting the 3′ UTR and inducing translation repression of the gene.

3.. Discussion
==============

Endothelial dysfunction, e.g., apoptosis, is an initiative stage of atherosclerosis. Particularly, the ox-LDL induced apoptosis in endothelial cells raises concern, because ox-LDL is a major risk factor in the development of atherosclerosis. We utilized a permanent endothelial cell line (EAhy926) to evaluate the ox-LDL-induced apoptosis. It was shown that ox-LDL could reduce the EAhy926 cell viability by inducing apoptosis, and the apoptosis was induced in a dose-dependent way ([Figure 1](#f1-ijms-14-22708){ref-type="fig"}).

Accumulating evidence suggests important roles of miRNAs in vascular diseases through regulating target molecules expression in endothelial cells. Angiogenesis, migration, and proliferation of endothelial cells could be regulated by miR-424, hsa-let-7gcluster, miR-221 and miR-222 \[[@b20-ijms-14-22708]--[@b22-ijms-14-22708]\]; the vascular inflammation had been contributed by miR-155, miR-31, and miR-126 \[[@b23-ijms-14-22708]\]. Further, microRNAs, such as miR-146a, miR-181a, miR-29b and miRNA let-7g, were reported to be involved in the ox-LDL-induced atherosclerosis \[[@b15-ijms-14-22708],[@b24-ijms-14-22708]--[@b26-ijms-14-22708]\]. Thus, the identification of miRNAs and their targets may cast new light on the mechanism and therapeutic strategies of (to) atherosclerosis. Previously, we utilized a miRNA microarray to analyze the miRNA expression profile in ox-LDL induced apoptotic EAhy926 cells. Let-7g was one of the most downregulated miRNAs post ox-LDL treatment (Data not shown). The preliminary results gave an important indication of miRNAs associated with atherosclerosis. In the present study, we confirmed the suppression of miRNA let-7g in the ox-LDL-treated EAhy926 endothelial cells by RT-qPCR ([Figure 3a](#f3-ijms-14-22708){ref-type="fig"}). In addition, the possible roles of let-7g in ox-LDL-induced atherosclerosis were identified.

The let-7 family is composed of 12 members (let-7-a1, a2, a3, b, c, d, e, f1, f2, g, i and miR-98) located on 8 different chromosomes \[[@b27-ijms-14-22708]\]. It has been demonstrated that let-7 family is one of most expressed microRNAs in endothelial cells \[[@b28-ijms-14-22708]\]. In addition, let-7 family members have been described to promote endothelial cell proliferation and angiogenesis by targeting antiangiogenic genes \[[@b20-ijms-14-22708],[@b29-ijms-14-22708],[@b30-ijms-14-22708]\]. Furthermore, the let-7 family members were reported to be linked to hypertension and atherosclerosis \[[@b31-ijms-14-22708],[@b32-ijms-14-22708]\]. Particularly, the let-7g could regulate the ox-LDL-induced atherosclerosis by targeting ox-LDL receptor LOX-1 \[[@b14-ijms-14-22708]\]. The let-7 family members have also been described to exert anti-apoptotic effect in diverse biological processes \[[@b33-ijms-14-22708]\]. In this study, TargetScan analysis showed a complementation of let-7g miRNA with the CASP3 3′ UTR ([Figure 5a](#f5-ijms-14-22708){ref-type="fig"}). In addition, the CASP3 expression in protein level was inhibited by the transfection of the has-let-7g mimics, while no effect was found for the control transfection. Furthermore, the luciferase reporter constructs containing the 3′ UTR of CASP3 mRNA reconfirmed the suppression of CASP3 by has-let-7g mimics in EAhy926 cells. Taken together, let-7g downregulates CASP3 by targeting the 3′ UTR and inducing translation repression of the gene.

CASP3 is considered as the major executioner caspase in apoptosis. By targeting CASP3, has-let-7g mimics reduced the ox-LDL-induced apoptosis significantly in EAhy926 cells ([Figure 4b](#f4-ijms-14-22708){ref-type="fig"}). Therefore, let-7g may play an important role in the regulation of ox-LDL-induced apoptosis and atherosclerosis. In addition to apoptosis, CASP3 is also known to be important in non-apoptotic events, such as cell cycle regulation, cell migration, cell differentiation \[[@b34-ijms-14-22708]--[@b36-ijms-14-22708]\]. By targeting CASP3, let-7g might also be involved in the regulation of other cellular events involved in atherosclerosis. Therefore, the significance of the present finding about the association of let-7g with CASP3 is yet to be explored. Nevertheless, such kind of studies might lead to the future development of an alternative strategy that targeting at let-7g in treatment of atherosclerosis.

4.. Method and Materials
========================

4.1.. Reagents and Cell Cultures
--------------------------------

Ox-LDL was purchased from Biomedical Technologies Inc. (Stoughton, MA, USA) and resolved in the RPMI 1640 medium supplemented with 2% FBS. Because of the nonspecific detergent activity of ox-LDL, especially at high concentration (\>50 μg/mL), the maximal concentration of ox-LDL was 50 μg/mL. EAhy926 cells were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA) and limitedly propagated in RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% FBS (Gibco, Rockville, MD, USA) and 0.2% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA) at 37 °C under 5% CO~2~. The RPMI 1640 medium supplemented with 2% FBS replaced the medium supplemented with 10% FBS, after the EAhy926 cells grew to about 90% confluence, and were treated with ox-LDL of various concentration for various h. Post ox-LDL incubation, the cells were lyzed for the mRNA expression analysis or for the western blotting analysis.

4.2.. Cell Viability Assay
--------------------------

Cell viability was evaluated by methyl thiazolyl tetrazoliym assay (MTT assay) (Invitrogen, Carlsbad, CA, USA). EAhy926 cells were cultured in 96-well plates and incubated at 37 °C for 24 h, then cells were changed with RPMI 1640 medium containing 2% FBS and ox-LDL (0, 10, or 30 μg/mL), and were continued incubating for up to 0, 6, 12 or 24 h. After that, cells were incubated with 50 μL MTT solution at 37 °C for another 2 h, and were dissolved by 150 μL DMSO completely at room temperature. The optical density was then measured at 570 nm using a spectrophotometer (Bio-Rad, Hercules, CA, USA).

4.3.. Apoptosis Assays
----------------------

Cell apoptosis was determined by an annexin V-FITC apoptosis detection kit (Sigma-Aldrich, St. Louis, MO, USA). Briefly, 1--5 × 10^5^ EAhy926 cells post being treated with 0 or 30 μg/mL ox-LDL, resolved in RPMI 1640 medium containing 2% FBS, were collected and resuspended in 0.5 mL of binding buffer and incubated with annexin V-FITC and propidium iodide for 10 min in the dark at room temperature. A FACScan flow cytometer (Bio-Rad, Hercules, CA, USA) equipped with a FITC signal detector FL1 (excitation 488 nm, green) and a phycoerythrin emission signal detector FL3 (excitation 585 nm, red) was used to analyze cellular apoptosis. The results were calculated using the CellQuest^™^ Pro software (BD Biosciences) and expressed as the percentage of apoptotic cells from the total cells. To determine the effect of has-let-7g on the apoptosis induced by ox-LDL, the synthetic has-let-7g mimics or miRNA control (GenePharma, Shanghai, China) were utilized. EAhy926 cells were transfected with 50 nM has-let-7g mimics or miRNA control, 6 h later; the cells were inoculated with RPMI 1640 medium supplemented with 2% FBS, and with 50 μg/mL ox-LDL for 0, 24 or 48 h. Then the cell apoptosis was determined.

4.4.. RNA Isolation, Reverse Transcription, qPCR
------------------------------------------------

Total cellular RNA from about 10^5^ cells was prepared with PureLink^®^ RNA Mini Kit (Invitrogen, Carlsbad, CA, USA); miRNAs was isolated using mirVana^™^ miRNA Isolation Kit (Ambion, Austin, TX, USA). In addition, reverse transcription-PCR (RT-PCR) was performed with Takara One Step RT-PCT kit (Takara, Dalian, China). For quantitative analysis of mRNA expression of LOX-1, Bax, CASP3, Drosha, Dicer, The resulting cDNAs were amplified using primer/probe sets specific for the genes of interest on a Lightcycler 480 II (Roche, Mannheim, Germany). Relative quantification was determined using the ΔΔ*Ct* method using GAPDH as reference genes. The primers used were available upon a request.

4.5.. Immunoblotting
--------------------

About 10^5^ cells were lyzed with cell lysis reagent (Promega, Madison, WI, USA), and supplemented with Complete Mini protease inhibitor cocktail (Roche, Basel, Switzerland). After protein concentration determination using Bradford Reagent (Bio-Rad, Hercules, CA, USA), the protein samples were separated onto a 4%--20% gradient SDS-PAGE gel, transferred to PVDF membrane and blocked in 5% skimmed milk. The following primary antibodies were utilized: LOX-1 rabbit polyclonal antibody, 1:300 (Sino Biological, Beijing, China), CASP3 rabbit polyclonal antibody, 1:500 (Sigma-Aldrich, St. Louis, MO, USA), Dicer rabbit polyclonal, 1:500 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); Drosha rabbit polyclonal, 1:500 (Santa Cruz Biotechnology); and GAPDH rabbit polyclonal, 1:1000 (Sigma-Aldrich, St. Louis, MO, USA). All immunoblots are representative of at least three independent experiments.

4.6.. Overexpression of Hsa-Let-7g
----------------------------------

Hsa-let-7g miRNA mimics (QIAGEN, Valencia, CA, USA) were utilized to overexpress the has-let-7g. For analysis of hsa-let-7 suppressing apoptosis, 50 nM miRNA mimics or miRNA control was transfected into EAhy926 cells with lipofectamine 2000. Post six hours' transfection, cells were treated with ox-LDL for 0, 24 or 48 h for let-7g expression and apoptosis analysis; or were treated with ox-LDL for 0, 12 or 24 h for Bax, or CASP3 expression analysis.

4.7.. Luciferase Activity Assay
-------------------------------

Reporter plasmid with CASP3 3′UTR (pEZX-MT05) was purchased from GeneCopoeia, Inc (Rockville, MD, USA). Briefly, 3.5 × 10^5^ EAhy926 cells were transfected with 25 or 50 nM of miRNA control or has-let-7g mimics, and 0.5 μg pEZX-MT05 reporter plasmid with Lipofectamine 2000 according to the manufacturer's instructions. The medium was replaced with RPMI 1640 containing 10% FBS at 6 h post-transfection. At 24 h post-transfection, cells were harvested for analysis. Luciferase activity was determined by using a Promega luciferase assay system. Experiments were done in triplicate, and means were determined.

5.. Conclusions
===============

We found that miRNA let-7g was suppressed during the ox-LDL-induced apoptosis in EAhy926 endothelial cells. In addition, overexpression of let-7g negatively regulated apoptosis in the endothelial cells by targeting CASP3 expression. Therefore, miRNA let-7g may play an important role in endothelial apoptosis and atherosclerosis.
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![Ox-LDL decreased the EAhy926 cell viability by inducing apoptosis. (**a**) Viability of EAHY926 cells significantly decreased 12, or 24 h post treatment with 30 μg/mL ox-LDL; (**b**) Apoptosis of EAhy926 cells without ox-LDL treatment; (**c**) Apoptosis of EAhy926 cells post 30 μg/mL ox-LDL treatments. And (**d**) significant upregulation in apoptosis of EAhy926 cells with ox-LDL treatment than of EAhy926 cells without ox-LDL treatment. The results are expressed as percentages of positive mean values ± S.E. for three independent experiments. \* *p* \< 0.05, \*\* *p* \< 0.01.](ijms-14-22708f1){#f1-ijms-14-22708}

![Ox-LDL upregulated LOX-1 and apoptosis-associated molecules. (**a**) The mRNA expressions of LOX-1, Bax in EAhy926 cells were significant upregulated 6 h post ox-LDL treatment. (**b**) The mRNA expressions of LOX-1, Bax and CASP3 in EAhy926 cells were significant upregulated 12 h post ox-LDL treatment. (**c**) and (**d**) The western blot analysis for LOX-1, BAX and CASP 3 of EAhy926 cells post ox-LDL treatment. All results are representative of at least three independent experiments. \* *p* \< 0.05, \*\* *p* \< 0.01.](ijms-14-22708f2){#f2-ijms-14-22708}

![Let-7g was downregulated during the ox-LDL-induced apoptosis. (**a**) RT-qPCR for has-let-7g (**a**), Dicer (**b**) and Drosha (**c**) in EAhy926 cells treated with various concentrations of ox-LDL, all results were normalized to the GAPDH. (**d**) and (**e**) Western blot analysis of Drosha and Dicer in EAhy926 cells treated with various concentrations of ox-LDL. All results are expressed as mean values ± S.E. for three independent experiments. \* *p* \< 0.05, \*\* *p* \< 0.01.](ijms-14-22708f3){#f3-ijms-14-22708}

![Let-7g inhibited apoptosis and apoptosis-associated molecules expression in the EAhy926 cells. (**a**) The expression of has-let-7g was significantly upregulated in EAhy926 cells post transfecting with has-let-7g mimics than with miR-control at a 50 nM concentration; (**b**) ox-LDL induced apoptosis was suppressed in EAhy926 cells transfecting with has-let-7g mimics. The results were expressed as percentage for apoptotic cells; (**c**) and (**d**) Bax and CASP3 mRNA were downregulated post 50 nM has-let-7g mimics transfection and 50 μg/mL ox-LDL treatment; Bax and CASP3 protein level post has-let-7g mimics (**e**) or miRNA control (**f**) and 50 μg/mL ox-LDL treatment, for 0, 12 or 24 h. All results are expressed as mean values ± S.E. for three independent experiments. \* *p* \< 0.05, \*\* *p* \< 0.01.](ijms-14-22708f4){#f4-ijms-14-22708}

![Let-7g targeted on the 3′ UTR of CASP3 and decreased the CASP3 expression. (**a**) Hsa-let-7g/CASP3 alignment by the Targetscan analysis; Hsa-let-7g suppressed CASP3 expression in mRNA level (**b**) or protein level (**e**) and (**f**). 24 h post treating with 50 μg/mL ox-LDL and transfecting with miRNA control or hsa-let-7g, EAhy926 cells were quantitatively determined for the CASP3 expression at mRNA level (**b**) and at protein level (**e**, **f**), compared to GAPDH. (**c**) Schematic diagram of pEZX-MT05 plasmid with CASP3 3′ UTR. (**d**) Relative luciferase activity in EAhy926 cells 24 h post transfecting with miRNA control or has-let-7g mimics. All results were averaged with three independent experiments. Statistical significance was shown in the figure. \* *p* \< 0.05, \*\* *p* \< 0.01.](ijms-14-22708f5){#f5-ijms-14-22708}
